title: Drug company sponsorship of education: the response to the FDA draft concept paper.
authors.forename: E J
authors.initials: EJ
authors.lastname: Lazar
authors.forename: D
authors.initials: D
authors.lastname: Banks
authors.forename: C
authors.initials: C
authors.lastname: Graham
authors.forename: D
authors.initials: D
authors.lastname: Adams
authors.forename: P H
authors.initials: PH
authors.lastname: Rheinstein
authors.forename: M
authors.initials: M
authors.lastname: Gross
authors.forename: A M
authors.initials: AM
authors.lastname: Witt
mesh_terms: D035843:Biomedical Research; D004345:Drug Industry; D004502:Education, Medical, Continuing; D035082:Federal Government; D033161:Government Regulation; D014481:United States; D014486:United States Food and Drug Administration